NCT06680427View on ClinicalTrials.gov

Siegel™ Transcatheter Aortic Valve Replacement System (TAVR) Early Feasibility Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

March 26, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Aortic Stenosis Symptomatic
Interventions
DEVICE

Siegel Transcatheter Aortic Valve (TAVR)

Replacement of native aortic valve with the Siegel Transcatheter Aortic Valve (TAVR) by a transfemoral approach.

Trial Locations (8)

10032

Columbia University Medical Center/ NYPH, New York

30309

Piedmont Healthcare, Atlanta

34102

NCH Healthcare System, Naples

44195

Cleveland Clinic, Cleveland

55905

Mayo Clinic, Rochester

90071

Cedars-Sinai Medical Center, Los Angeles

94304

Stanford, Palo Alto

07960

Atlantic Health System, Morristown

Sponsors

Lead Sponsor

MiRus
All Listed Sponsors
lead

MiRus

INDUSTRY